Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 2/20 | 0.52 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.50 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.50 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 5/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 2/20 | 0.43 |
| ▸ | CTSB | P07858 | 2/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29110345 | 0.99 | SLC15A1 (0.51) | SLC15A1CACNA2D1CACNB3CACNA1CPGR | |
| Hydrochloric Acid SCHEMBL1044439 | 0.99 | SLC15A1 (0.51) | SLC15A1CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL10013280 | 0.87 | ALDH1A1 (0.50) | SLC15A1ALDH1A1MAPK1L3MBTL1CTSK | |
| SCHEMBL16726827 | 0.87 | ALDH1A1 (0.50) | SLC15A1ALDH1A1MAPK1L3MBTL1CTSK | |
| SCHEMBL13915926 | 0.84 | SLC15A1 (0.48) | SLC15A1ALDH1A1MAPK1L3MBTL1CTSK | |
| SCHEMBL16729374 | 0.83 | SLC15A1 (0.47) | SLC15A1ALDH1A1MAPK1L3MBTL1CTSK | |
| SCHEMBL7365728 | 0.82 | SLC15A1 (0.57) | SLC15A1ALDH1A1MAPK1L3MBTL1MMP9 | |
| SCHEMBL111390 | 0.81 | ALDH1A1 (0.61) | SLC15A1ALDH1A1MAPK1L3MBTL1CTSK | |
| SCHEMBL1974104 | 0.81 | SLC15A1 (0.45) | SLC15A1ALDH1A1MAPK1L3MBTL1CTSK | |
| SCHEMBL27674121 | 0.80 | ALDH1A1 (0.59) | SLC15A1ALDH1A1MAPK1L3MBTL1CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9925204-B2 | Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation | KAWAI TOSHIHISA (US) | 2018-03-27 | — | — | US | disclosed |
| US-20160317575-A1 | ANTI-INFLAMMATORY COMPOUNDS IN COMBINATION WITH HYDROGEN FOR THE TREATMENT OF INFLAMMATION | KAWAI TOSHIHISA (US) | 2016-11-03 | — | — | US | disclosed |
| US-20160317575-A1 | ANTI-INFLAMMATORY COMPOUNDS IN COMBINATION WITH HYDROGEN FOR THE TREATMENT OF INFLAMMATION | KAWAI TOSHIHISA (US) | 2016-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160317575-A1 | ANTI-INFLAMMATORY COMPOUNDS IN COMBINATION WITH HYDROGEN FOR THE TREATMENT OF INFLAMMATION | PTGS1, HVCN1, HRH2 | SLC15A1 1697/4885CACNA2D1 1262/4885CACNB3 581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.